Get started
Author

Sol Jarchum

Observed names: Jarchum, S., Jarchum, Sol, S. Jarchum
Institution: Fundacion Allende
ORCID: 0000-0002-9235-7941
Observed ORCID: 0000-0002-9235-7941
OpenAlex ID: A5016167402
Determinación de algunos marcadores de estrés oxidativo, funcionales e inmunológicos en saliva de pacientes sometidos a trasplante de médula ósea (TMO).
2021 · Evelin Bachmeier, María Elena Migueles Goitea, et al. · Revista de la Facultad de Ciencias Médicas de Córdoba · 6
PDF
Clinical characteristics and evolution of hematological patients and COVID-19 in Argentina: a report from the Argentine Society of Hematology.
2021 · Ana L Basquiera, Mercedes J García, et al. · PubMed · 6
ABCL-449 Mediastinal Large B Cell Lymphoma (MLBL): Evaluation of PET Deauville 4 (D4) at the End of Treatment (EOT)
2024 · Malena Rocca, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America
2023 · Mariano Berro, Nelson Hamerschlak, et al. · Hematology/Oncology and Stem Cell Therapy · 1
PDF
Determination of Streptococcus sp. and Candida albicans in the oral cavity of patients undergoing bone marrow transplantation
2021 · Evelin Bachmeier, María Elena Migueles Goitea, et al. · Journal Of Oral Research · 1
POSTER: ABCL-257: Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated With Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study
2026 · Juliana Faleschini, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-257: Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated With Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study
2026 · Juliana Faleschini, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-256: EASIX Score Predicts Severe Acute Graft-vs-Host Disease and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study
2026 · Juliana Faleschini, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-256: EASIX Score Predicts Severe Acute Graft-vs-Host Disease and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study
2026 · Juliana Faleschini, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
¿Son los anticuerpos biespecíficos la llave para rescatar al linfoma difuso a grandes células recaído/ refractario (RR-DLBCL) en contextos con acceso limitado a CART? Evidencia argentina con epcoritamab en uso compasivo
2026 · Carolina Mahuad, Mariela Gomez, et al. · Revista Hematología
PDF
Bridging the CART gap: Epcoritamab as a feasible option for relapsed/refractory DLBCL in CART-inaccessible regions - “the argentine experience”
2025 · Carolina Mahuad, Mariela Gomez, et al. · Blood
Ex-Vivo Testing of Myeloma Cells and Autologous Effector Cells from the Tumor Microenvironment Unveils Differential Response to Daratumumab and Isatuximab
2024 · Constanza Marin, Maribel Nicola, et al. · Blood
PDF
Mediastinal Large B-Cell Lymphoma (MLBL): Evaluation of PET Deauville 4 (D4) at the End of Treatment (EOT)
2024 · Malena Rocca, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-319 Prognostic Value of EASIX Score in Allogeneic Hematopoietic Stem Cell Transplantation
2024 · Juliana Faleschini, Evelyn Colombo, et al. · Clinical Lymphoma Myeloma & Leukemia
Prognostic Value of EASIX Score in Allogeneic Hematopoietic Stem Cell Transplantation
2024 · Juliana Faleschini, Evelyn Colombo, et al. · Clinical Lymphoma Myeloma & Leukemia
High Progression Free Survival Rates in Patients with Multiply Relapsed/Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant after Checkpoint Inhibitors: Results from Grupo Argentino De Trasplante De Medula Osea y Terapia Celular (GATMO-TC)
2023 · Laura Korin, Martin Castro, et al. · Blood
PDF
ABCL-328: Lymphoma Associated with HIV Infection: Prevalence, Clinical Characteristics, Treatment, and Outcomes
2020 · Rodrigo Meneces Bustillo, Evelyn Colombo, et al. · Clinical Lymphoma Myeloma & Leukemia
Prevalence of Helicobacter pylori in Stem Cell Transplants Patients from Argentina and Its Influence in Outcomes
2019 · Veronica Musso, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: Comparison BEAM / BEAC-BUCY-GEMBUMEL
2018 · Evelyn Colombo, Sol Jarchum, et al. · Clinical Lymphoma Myeloma & Leukemia
Brentuximab vedotin: A retrospective multicenter analysis of its indication, safety and efficacy in Argentina
2017 · M.F. Negri Aranguren, C. Shanley, et al. · Hematological Oncology
PDF
Trasplante alogénico de células progenitoras hematopoyéticas en pacientes con mielofibrosis: resultados del Grupo Argentino de Trasplante de Médula Ósea (GATMO)
2017 · Basquiera, Ana L., Guanchiale, Luciana, et al. · Revista Hematología
PDF
Works count: 23
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type